LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 11

Search options

  1. Article ; Online: Perioperative Periprosthetic Femur Fractures are Strongly Correlated With Fixation Method: an Analysis From the American Joint Replacement Registry.

    Springer, Bryan D / Etkin, Caryn D / Shores, Peter B / Gioe, Terence J / Lewallen, David G / Bozic, Kevin J

    The Journal of arthroplasty

    2019  Volume 34, Issue 7S, Page(s) S352–S354

    Abstract: Background: Perioperative periprosthetic femur fractures (PPFx) after total hip arthroplasty (THA) remain a leading cause of early stem failure and revision and are associated with high rates of morbidity and mortality. American Joint Replacement ... ...

    Abstract Background: Perioperative periprosthetic femur fractures (PPFx) after total hip arthroplasty (THA) remain a leading cause of early stem failure and revision and are associated with high rates of morbidity and mortality. American Joint Replacement Registry (AJRR) data have been analyzed to determine the relationship of femoral stem fixation to PPFx revision.
    Methods: All early (≤3 months from index arthroplasty) linked primary and revision hip arthroplasties reported to the AJRR between 2012 and 2017 were analyzed. We evaluated patient demographics, arthroplasty type (hemiarthroplasty vs THA), and stem fixation.
    Results: A total of 10,277 linked revisions were reported to the AJRR during 2012-2017. Early PPFx requiring revision occurred in 628 patients (6.1%) due to osteoarthritis (82.4%), femoral neck fracture (12.1%), and other causes (15.6%). Five hundred twenty-nine patients (84%) were treated with THA and 99 patients with hemiarthroplasty (16%). Females (70%) have a higher prevalence of revisions. Fifty-eight percent of patients were ≥70 years of age, and 20% were ≥80 years of age. Patients with cementless stems were 2.6 times (account 94.9% of the fractures, 95% confidence interval 0.59-11.1) more likely to undergo early revision for PPFx than those with cemented fixation, although not statistically significant with its sample size.
    Conclusion: Mirroring other studies and national registries, there was an association between cementless fixation and PPFx in AJRR. Nevertheless, AJRR data demonstrate a trend of increasing utilization of cementless femoral fixation for THA and hemiarthroplasty, with cementless fixation accounting for 93% of THA stems with early periprosthetic fracture. Additional analysis is needed to better understand this phenomenon, especially in the elderly.
    MeSH term(s) Aged ; Aged, 80 and over ; Arthroplasty, Replacement, Hip/adverse effects ; Female ; Femoral Fractures/complications ; Femoral Fractures/surgery ; Femoral Neck Fractures/surgery ; Femur/surgery ; Fracture Fixation/adverse effects ; Fracture Fixation/methods ; Hemiarthroplasty/adverse effects ; Hip Prosthesis/adverse effects ; Humans ; Male ; Middle Aged ; Periprosthetic Fractures/surgery ; Prosthesis Design ; Registries ; Reoperation/statistics & numerical data ; Risk Factors ; United States
    Language English
    Publishing date 2019-02-10
    Publishing country United States
    Document type Journal Article
    ZDB-ID 632770-9
    ISSN 1532-8406 ; 0883-5403
    ISSN (online) 1532-8406
    ISSN 0883-5403
    DOI 10.1016/j.arth.2019.02.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Mixed Treatment Comparisons for Nonsurgical Treatment of Knee Osteoarthritis: A Network Meta-analysis.

    Jevsevar, David S / Shores, Peter B / Mullen, Kyle / Schulte, Danielle M / Brown, Gregory A / Cummins, Deborah S

    The Journal of the American Academy of Orthopaedic Surgeons

    2018  Volume 26, Issue 9, Page(s) 325–336

    Abstract: Introduction: Knee osteoarthritis (KOA) is a significant health problem with lifetime risk of development estimated to be 45%. Effective nonsurgical treatments are needed for the management of symptoms.: Methods: We designed a network meta-analysis ... ...

    Abstract Introduction: Knee osteoarthritis (KOA) is a significant health problem with lifetime risk of development estimated to be 45%. Effective nonsurgical treatments are needed for the management of symptoms.
    Methods: We designed a network meta-analysis to determine clinically relevant effectiveness of nonsteroidal anti-inflammatory drugs, acetaminophen, intra-articular (IA) corticosteroids, IA platelet-rich plasma, and IA hyaluronic acid compared with each other as well as with oral and IA placebos. We used PubMed, EMBASE, and Cochrane Central Register of Controlled Trials to perform a systematic search of KOA treatments with no date limits and last search on October 7, 2015. Article inclusion criteria considered the following: target population, randomized controlled study design, English language, human subjects, treatments and outcomes of interest, ≥30 patients per group, and consistent follow-up. Using the best available evidence, two abstractors independently extracted pain and function data at or near the most common follow-up time.
    Results: For pain, all active treatments showed significance over oral placebo, with IA corticosteroids having the largest magnitude of effect and significant difference only over IA placebo. For function, no IA treatments showed significance compared with either placebo, and naproxen was the only treatment showing clinical significance compared with oral placebo. Cumulative probabilities showed naproxen to be the most effective individual treatment, and when combined with IA corticosteroids, it is the most probable to improve pain and function.
    Discussion: Naproxen ranked most effective among conservative treatments of KOA and should be considered when treating pain and function because of its relative safety and low cost. The best available evidence was analyzed, but there were instances of inconsistency in the design and duration among articles, potentially affecting uniform data inclusion.
    MeSH term(s) Acetaminophen/therapeutic use ; Adrenal Cortex Hormones/administration & dosage ; Adrenal Cortex Hormones/therapeutic use ; Analgesics, Non-Narcotic/therapeutic use ; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Humans ; Hyaluronic Acid/therapeutic use ; Injections, Intra-Articular ; Musculoskeletal Pain/drug therapy ; Musculoskeletal Pain/etiology ; Naproxen/therapeutic use ; Network Meta-Analysis ; Osteoarthritis, Knee/complications ; Osteoarthritis, Knee/drug therapy ; Osteoarthritis, Knee/physiopathology ; Platelet-Rich Plasma
    Chemical Substances Adrenal Cortex Hormones ; Analgesics, Non-Narcotic ; Anti-Inflammatory Agents, Non-Steroidal ; Acetaminophen (362O9ITL9D) ; Naproxen (57Y76R9ATQ) ; Hyaluronic Acid (9004-61-9)
    Language English
    Publishing date 2018-04-24
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Meta-Analysis ; Review
    ZDB-ID 1200524-1
    ISSN 1940-5480 ; 1067-151X
    ISSN (online) 1940-5480
    ISSN 1067-151X
    DOI 10.5435/JAAOS-D-17-00318
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The Efficacy of Tranexamic Acid in Total Knee Arthroplasty: A Network Meta-Analysis.

    Fillingham, Yale A / Ramkumar, Dipak B / Jevsevar, David S / Yates, Adolph J / Shores, Peter / Mullen, Kyle / Bini, Stefano A / Clarke, Henry D / Schemitsch, Emil / Johnson, Rebecca L / Memtsoudis, Stavros G / Sayeed, Siraj A / Sah, Alexander P / Della Valle, Craig J

    The Journal of arthroplasty

    2018  Volume 33, Issue 10, Page(s) 3090–3098.e1

    Abstract: Background: A growing body of published research on tranexamic acid (TXA) suggests that it is effective in reducing blood loss and the risk for transfusion in total knee arthroplasty (TKA). The purpose of this network meta-analysis was to evaluate TXA ... ...

    Abstract Background: A growing body of published research on tranexamic acid (TXA) suggests that it is effective in reducing blood loss and the risk for transfusion in total knee arthroplasty (TKA). The purpose of this network meta-analysis was to evaluate TXA in primary TKA as the basis for the efficacy recommendations of the combined clinical practice guidelines of the American Association of Hip and Knee Surgeons, American Academy of Orthopaedic Surgeons, Hip Society, Knee Society, and American Society of Regional Anesthesia and Pain Medicine on the use of TXA in primary total joint arthroplasty.
    Methods: We searched Ovid MEDLINE, Embase, Cochrane Reviews, Scopus, and Web of Science databases for publications before July 2017 on TXA in primary total joint arthroplasty. All included studies underwent qualitative and quantitative homogeneity testing. Direct and indirect comparisons were performed as a network meta-analysis, and results were tested for consistency.
    Results: After critical appraisal of the available 2113 publications, 67 articles were identified as representing the best available evidence. Topical, intravenous (IV), and oral TXA formulations were all superior to placebo in terms of decreasing blood loss and risk of transfusion, while no formulation was clearly superior. Use of repeat IV and oral TXA dosing and higher doses of IV and topical TXA did not significantly reduce blood loss or risk of transfusion. Preincision administration of IV TXA had inconsistent findings with a reduced risk of transfusion but no effect on volume of blood loss.
    Conclusions: Strong evidence supports the efficacy of TXA to decrease blood loss and the risk of transfusion after primary TKA. No TXA formulation, dosage, or number of doses provided clearly improved blood-sparing properties for TKA. Moderate evidence supports preincision administration of IV TXA to improve efficacy.
    MeSH term(s) Antifibrinolytic Agents/administration & dosage ; Antifibrinolytic Agents/adverse effects ; Antifibrinolytic Agents/therapeutic use ; Arthroplasty, Replacement, Knee/adverse effects ; Blood Loss, Surgical/prevention & control ; Female ; Humans ; Network Meta-Analysis ; Tranexamic Acid/administration & dosage ; Tranexamic Acid/adverse effects ; Tranexamic Acid/therapeutic use
    Chemical Substances Antifibrinolytic Agents ; Tranexamic Acid (6T84R30KC1)
    Language English
    Publishing date 2018-05-05
    Publishing country United States
    Document type Journal Article ; Meta-Analysis ; Research Support, Non-U.S. Gov't
    ZDB-ID 632770-9
    ISSN 1532-8406 ; 0883-5403
    ISSN (online) 1532-8406
    ISSN 0883-5403
    DOI 10.1016/j.arth.2018.04.043
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Response to Letter to the Editor on "The Safety of Tranexamic Acid in Total Joint Arthroplasty: A Direct Meta-Analysis".

    Fillingham, Yale A / Ramkumar, Dipak B / Jevsevar, David S / Yates, Adolph J / Shores, Peter / Mullen, Kyle / Bini, Stefano A / Clarke, Henry D / Schemitsch, Emil / Johnson, Rebecca L / Memtsoudis, Stavros G / Sayeed, Siraj A / Sah, Alexander P / Della Valle, Craig J

    The Journal of arthroplasty

    2018  Volume 33, Issue 10, Page(s) 3368–3369

    MeSH term(s) Antifibrinolytic Agents ; Arthroplasty ; Blood Loss, Surgical ; Humans ; Tranexamic Acid
    Chemical Substances Antifibrinolytic Agents ; Tranexamic Acid (6T84R30KC1)
    Language English
    Publishing date 2018-05-29
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 632770-9
    ISSN 1532-8406 ; 0883-5403
    ISSN (online) 1532-8406
    ISSN 0883-5403
    DOI 10.1016/j.arth.2018.05.029
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The Efficacy of Tranexamic Acid in Total Hip Arthroplasty: A Network Meta-analysis.

    Fillingham, Yale A / Ramkumar, Dipak B / Jevsevar, David S / Yates, Adolph J / Shores, Peter / Mullen, Kyle / Bini, Stefano A / Clarke, Henry D / Schemitsch, Emil / Johnson, Rebecca L / Memtsoudis, Stavros G / Sayeed, Siraj A / Sah, Alexander P / Della Valle, Craig J

    The Journal of arthroplasty

    2018  Volume 33, Issue 10, Page(s) 3083–3089.e4

    Abstract: Background: Tranexamic acid (TXA) is an antifibrinolytic agent commonly used to reduce blood loss in total hip arthroplasty (THA). The purpose of our study was to evaluate the efficacy of TXA in primary THA to support the combined clinical practice ... ...

    Abstract Background: Tranexamic acid (TXA) is an antifibrinolytic agent commonly used to reduce blood loss in total hip arthroplasty (THA). The purpose of our study was to evaluate the efficacy of TXA in primary THA to support the combined clinical practice guidelines of the American Association of Hip and Knee Surgeons, American Academy of Orthopaedic Surgeons, Hip Society, Knee Society, and American Society of Regional Anesthesia and Pain Medicine on the use of TXA in primary total joint arthroplasty.
    Methods: A search was performed using Ovid-MEDLINE, Embase, Cochrane Reviews, Scopus, and Web of Science databases to identify all publications before July 2017 on TXA in primary THA. We completed qualitative and quantitative homogeneity testing of all included studies. Direct and indirect comparisons were analyzed using a network meta-analysis followed by consistency testing of the results.
    Results: Two thousand one hundred thirteen publications underwent critical appraisal with 34 publications identified as representing the best available evidence for inclusion in the analysis. Topical, intravenous, and oral TXA formulations provided reduced blood loss and risk of transfusion compared to placebo, but no formulation was clearly superior. Use of repeat doses, higher doses, or variation in timing of administration did not significantly reduce blood loss or risk of transfusion.
    Conclusions: Strong evidence supports the use of TXA to reduce blood loss and risk of transfusion after primary THA. No specific routes of administration, dosage, dosing regimen, or time of administration provides clearly superior blood-sparing properties.
    MeSH term(s) Antifibrinolytic Agents/administration & dosage ; Antifibrinolytic Agents/adverse effects ; Antifibrinolytic Agents/therapeutic use ; Arthroplasty, Replacement, Hip ; Blood Loss, Surgical/prevention & control ; Blood Transfusion ; Humans ; Network Meta-Analysis ; Tranexamic Acid/administration & dosage ; Tranexamic Acid/adverse effects ; Tranexamic Acid/therapeutic use ; Treatment Outcome
    Chemical Substances Antifibrinolytic Agents ; Tranexamic Acid (6T84R30KC1)
    Language English
    Publishing date 2018-06-27
    Publishing country United States
    Document type Journal Article ; Meta-Analysis ; Research Support, Non-U.S. Gov't
    ZDB-ID 632770-9
    ISSN 1532-8406 ; 0883-5403
    ISSN (online) 1532-8406
    ISSN 0883-5403
    DOI 10.1016/j.arth.2018.06.023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The Safety of Tranexamic Acid in Total Joint Arthroplasty: A Direct Meta-Analysis.

    Fillingham, Yale A / Ramkumar, Dipak B / Jevsevar, David S / Yates, Adolph J / Shores, Peter / Mullen, Kyle / Bini, Stefano A / Clarke, Henry D / Schemitsch, Emil / Johnson, Rebecca L / Memtsoudis, Stavros G / Sayeed, Siraj A / Sah, Alexander P / Della Valle, Craig J

    The Journal of arthroplasty

    2018  Volume 33, Issue 10, Page(s) 3070–3082.e1

    Abstract: Background: Tranexamic acid (TXA) is effective in reducing blood loss in total joint arthroplasty (TJA), but concerns still remain regarding the drug's safety. The purpose of this direct meta-analysis was to evaluate and establish a basis for the safety ...

    Abstract Background: Tranexamic acid (TXA) is effective in reducing blood loss in total joint arthroplasty (TJA), but concerns still remain regarding the drug's safety. The purpose of this direct meta-analysis was to evaluate and establish a basis for the safety recommendations of the combined clinical practice guidelines on the use of TXA in primary TJA.
    Methods: A search was completed for studies published before July 2017 on TXA in primary TJA. We performed qualitative and quantitative homogeneity testing and a direct comparison meta-analysis. We used the American Society of Anesthesiologists (ASA) score of 3 or greater as a proxy for patients at higher risk for complications in general and performed a meta-regression analysis to investigate the influence of comorbidity burden on the risk of arterial thromboembolic event and venous thromboembolic event (VTE).
    Results: Topical, intravenous, and oral TXA were not associated with an increased risk of VTE after TJA. In addition, meta-regression demonstrated that TXA use in patients with an ASA status of 3 or greater was not associated with an increased risk of VTE after total knee arthroplasty.
    Conclusion: Although most studies included in our analysis excluded patients with a history of prior thromboembolic events, our findings support the lack of evidence of harm from TXA administration in patients undergoing TJA. Moderate evidence supports the safety of TXA in patients undergoing total knee arthroplasty with an ASA score of 3 or greater. The benefits of using TXA appear to outweigh the potential risks of thromboembolic events even in patients with a higher comorbidity.
    MeSH term(s) Antifibrinolytic Agents/administration & dosage ; Antifibrinolytic Agents/adverse effects ; Antifibrinolytic Agents/therapeutic use ; Arthroplasty, Replacement/adverse effects ; Blood Loss, Surgical/prevention & control ; Humans ; Thromboembolism/chemically induced ; Thromboembolism/etiology ; Tranexamic Acid/administration & dosage ; Tranexamic Acid/adverse effects ; Tranexamic Acid/therapeutic use ; Treatment Outcome
    Chemical Substances Antifibrinolytic Agents ; Tranexamic Acid (6T84R30KC1)
    Language English
    Publishing date 2018-03-22
    Publishing country United States
    Document type Journal Article ; Meta-Analysis ; Research Support, Non-U.S. Gov't
    ZDB-ID 632770-9
    ISSN 1532-8406 ; 0883-5403
    ISSN (online) 1532-8406
    ISSN 0883-5403
    DOI 10.1016/j.arth.2018.03.031
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: The American Academy of Orthopaedic Surgeons Evidence-Based Guideline on Detection and Nonoperative Management of Pediatric Developmental Dysplasia of the Hip in Infants up to Six Months of Age.

    Mulpuri, Kishore / Song, Kit M / Gross, Richard Henry / Tebor, Gary B / Otsuka, Norman Yoshinobu / Lubicky, John P / Szalay, Elizabeth Ann / Harcke, H Theodore / Zehr, Bonnie / Spooner, Andrew / Campos-Outcalt, Doug / Henningsen, Charlotte / Jevsevar, David S / Goldberg, Michael / Brox, W Timothy / Shea, Kevin / Bozic, Kevin J / Shaffer, William / Cummins, Deborah /
    Murray, Jayson N / Mohiuddin, Mukarram / Shores, Peter / Woznica, Anne / Martinez, Yasseline / Sevarino, Kaitlyn

    The Journal of bone and joint surgery. American volume

    2015  Volume 97, Issue 20, Page(s) 1717–1718

    MeSH term(s) Disease Management ; Hip Dislocation, Congenital/diagnosis ; Hip Dislocation, Congenital/therapy ; Humans ; Infant ; Infant, Newborn ; Orthopedics ; Pediatrics
    Language English
    Publishing date 2015-10-21
    Publishing country United States
    Document type Journal Article ; Practice Guideline
    ZDB-ID 220625-0
    ISSN 1535-1386 ; 0021-9355
    ISSN (online) 1535-1386
    ISSN 0021-9355
    DOI 10.2106/JBJS.O.00500
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The American Academy of Orthopaedic Surgeons Evidence-Based Clinical Practice Guideline on Surgical Management of Osteoarthritis of the Knee.

    McGrory, Brian / Weber, Kristy / Lynott, John A / Richmond, John C / Davis, Charles Moore / Yates, Adolph / Kamath, Atul F / Dasa, Vinod / Brown, Gregory Alexander / Gerlinger, Tad L / Villanueva, Tomas / Piva, Sara / Hebl, James / Jevsevar, David / Shea, Kevin G / Bozic, Kevin J / Shaffer, William / Cummins, Deborah / Murray, Jayson N /
    Donnelly, Patrick / Patel, Nilay / Brenton, Ben / Shores, Peter / Woznica, Anne / Linskey, Erica / Sevarino, Kaitlyn

    The Journal of bone and joint surgery. American volume

    2016  Volume 98, Issue 8, Page(s) 688–692

    MeSH term(s) Evidence-Based Medicine ; Evidence-Based Practice ; Humans ; Orthopedic Procedures/standards ; Osteoarthritis, Knee/surgery
    Language English
    Publishing date 2016-04-20
    Publishing country United States
    Document type Journal Article ; Practice Guideline
    ZDB-ID 220625-0
    ISSN 1535-1386 ; 0021-9355
    ISSN (online) 1535-1386
    ISSN 0021-9355
    DOI 10.2106/JBJS.15.01311
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: The American Academy of Orthopaedic Surgeons Evidence-Based Clinical Practice Guideline on: Management of Carpal Tunnel Syndrome.

    Graham, Brent / Peljovich, Allan E / Afra, Robert / Cho, Mickey S / Gray, Rob / Stephenson, John / Gurman, Andrew / MacDermid, Joy / Mlady, Gary / Patel, Atul T / Rempel, David / Rozental, Tamara D / Salajegheh, Mohammad Kian / Keith, Michael Warren / Jevsevar, David S / Shea, Kevin G / Bozic, Kevin J / Adams, Julie / Evans, Jay Mark /
    Lubahn, John / Ray, Wilson Zachary / Spinner, Robert / Thomson, Grant / Shaffer, William O / Cummins, Deborah S / Murray, Jayson N / Mohiuddin, Mukarram / Mullen, Kyle / Shores, Peter / Woznica, Anne / Linskey, Erica / Martinez, Yasseline / Sevarino, Kaitlyn

    The Journal of bone and joint surgery. American volume

    2016  Volume 98, Issue 20, Page(s) 1750–1754

    MeSH term(s) Carpal Tunnel Syndrome/surgery ; Disease Management ; Evidence-Based Practice ; Humans ; Immobilization ; Orthopedic Surgeons ; Postoperative Care
    Language English
    Publishing date 2016-10-19
    Publishing country United States
    Document type Journal Article ; Practice Guideline
    ZDB-ID 220625-0
    ISSN 1535-1386 ; 0021-9355
    ISSN (online) 1535-1386
    ISSN 0021-9355
    DOI 10.2106/JBJS.16.00719
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: The American Academy of Orthopaedic Surgeons evidence-based guideline on management of anterior cruciate ligament injuries.

    Shea, Kevin G / Carey, James L / Richmond, John / Sandmeier, Robert / Pitts, Ryan T / Polousky, John D / Chu, Constance / Shultz, Sandra J / Ellen, Mark / Smith, Angela / LaBella, Cynthia R / Anderson, Allen F / Musahl, Volker / Myer, Gregory D / Meyer, Gregory D / Jevsevar, David / Bozic, Kevin J / Shaffer, William / Cummins, Deborah /
    Murray, Jayson N / Patel, Nilay / Shores, Peter / Woznica, Anne / Martinez, Yasseline / Gross, Leeaht / Sevarino, Kaitlyn

    The Journal of bone and joint surgery. American volume

    2015  Volume 97, Issue 8, Page(s) 672–674

    MeSH term(s) Anterior Cruciate Ligament/surgery ; Anterior Cruciate Ligament Injuries ; Anterior Cruciate Ligament Reconstruction/methods ; Anterior Cruciate Ligament Reconstruction/rehabilitation ; Exercise Therapy ; Humans ; Knee Injuries/diagnosis ; Knee Injuries/prevention & control ; Knee Injuries/rehabilitation ; Knee Injuries/surgery ; Physical Therapy Modalities ; Postoperative Care
    Language English
    Publishing date 2015-04-15
    Publishing country United States
    Document type Journal Article ; Practice Guideline
    ZDB-ID 220625-0
    ISSN 1535-1386 ; 0021-9355
    ISSN (online) 1535-1386
    ISSN 0021-9355
    DOI 10.2106/jbjs.n.01257
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top